The metabolic syndrome: inflammation, diabetes mellitus, and cardiovascular disease

Area of Science:

• Cardiovascular Science
• Metabolic Disease Research
• Inflammation Biomarkers

Background:

• Accumulating evidence links inflammation to cardiovascular disease (CVD) risk.
• Elevated high-sensitivity C-reactive protein (hs-CRP) levels correlate with increased risk for CVD and diabetes mellitus.
• Current metabolic syndrome definitions vary, impacting cardiovascular risk assessment.

Purpose of the Study:

• To evaluate the role of inflammation, specifically hs-CRP, in cardiovascular disease (CVD) and metabolic syndrome.
• To assess the impact of adding hs-CRP to metabolic syndrome criteria for improved CVD risk prediction.
• To highlight the need for a standardized metabolic syndrome definition that incorporates inflammation markers.

Main Methods:

• Review of existing evidence on inflammation markers and metabolic syndrome.
• Analysis of studies investigating hs-CRP association with CVD and diabetes mellitus.
• Comparison of current metabolic syndrome definitions and their predictive capabilities for cardiovascular risk.

Main Results:

• Elevated hs-CRP is associated with higher risks of CVD and diabetes mellitus.
• Incorporating hs-CRP into metabolic syndrome definitions enhances CVD risk prediction.
• hs-CRP levels may predict the future development of metabolic syndrome.

Conclusions:

• Inflammation, measured by hs-CRP, is a crucial factor in cardiovascular disease and metabolic syndrome.
• A refined definition of metabolic syndrome, potentially including hs-CRP, is needed for optimal risk prediction.
• Further research is required to establish a universally accepted criterion for metabolic syndrome that includes inflammatory markers.